Studies

I-PRESERVE

I-WOTCH

IABP-SHOCK II

ICAP

Icatibant in ACEi-induced angioedema

iCBT (secondary analysis, guided iCBT vs. self-guided iCBT)

iCBT (secondary analysis, guided iCBT vs. usual treatment)

ICE-CUB 2

ICON7

ICTOC

ICU-diary

ICU-ROX

IDEAL

IDEAL-ICU

iDIAPASON

IFR-SWEDEHEART

IIHTT

Iloprost in Traumatic Hemorrhagic Shock

ILUMIEN IV OPTICAL PCI

Imatinib-IPF

IMB-NIV program for CHRF

IMbrave 150

IMMUNOCITRE

IMPACT (cancer pain)

IMPACT (triple therapy vs. fluticasone/vilanterol)

IMPACT (triple therapy vs. umeclidinium/vilanterol)

IMpower133

ImpresU

IMPROVE

IMPROVE-IT

IMROZ

IMweanT

IND227

INDIGO

innovaTV 301

INPULSIS

INSIGHT START

INSPIRATION-S

INSPIRE-ASP PNA

INSPIRE-ASP UTI

INSPIRES (antiplatelet therapy)

INSPIRES (statin therapy)

INSTINCT

INTEGUMENT-1

INTEGUMENT-2

INTERACT2

Intravenous lidocaine after hepatectomy

INTREPID

INVESTED (secondary analysis)

INVICTUS

iPEGASUS

IPrEx

IRIS

IRONMAN

IRONOUT-HF

ISAR-TRIPLE

ISAT 1

ISCHEMIA

ITAC

ITACTIC

IV Thyroxine for Heart-Eligible Organ Donors

IVERCOR-COVID19

IVIO